Citadel Advisors - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is and the CUSIP is 87162T906. A total of 3 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$4,000
-69.2%
17,500
-51.4%
0.00%
Q4 2015$13,000
-74.5%
36,000
+22.9%
0.00%
Q3 2015$51,000
-27.1%
29,300
-6.4%
0.00%
Q2 2015$70,000
+42.9%
31,300
+23.2%
0.00%
Q1 2015$49,000
-46.7%
25,400
-27.2%
0.00%
Q4 2014$92,000
+4.5%
34,900
+19.1%
0.00%
Q3 2014$88,000
-26.1%
29,300
+0.3%
0.00%
Q2 2014$119,000
-35.0%
29,200
-31.3%
0.00%
Q1 2014$183,000
-14.5%
42,500
+4.2%
0.00%
Q4 2013$214,000
-26.7%
40,800
-11.7%
0.00%
Q3 2013$292,000
-0.7%
46,200
-21.6%
0.00%
-100.0%
Q2 2013$294,00058,9000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 71,800$160,0000.00%
SIMPLEX TRADING, LLC 48$00.00%
Citadel Advisors 31,300$70,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders